8-K: Current report filing
Published on July 20, 2007
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
___________________
FORM
8-K
___________________
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
Date
of
Report: July 16, 2007
(Date
of earliest event reported)
NOVELOS
THERAPEUTICS, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
333-119366
|
04-3321804
|
||
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
Number)
|
One
Gateway Center, Suite 504
Newton,
MA 02458
(Address
of principal executive offices)
(617)
244-1616
(Registrant's
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
| o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
| o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
| o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
| o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
5.03 Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal
Year
On
July
16, 2007, the shareholders of Novelos Therapeutics, Inc. (the “Company”)
approved an amendment to the Company’s Amended and Restated Certificate of
Incorporation to increase to 150,000,000 the number of shares of common stock,
par value $.00001, the Company is authorized to issue (the “Amendment”). The
Amendment became effective on July 16, 2007 upon the filing of the Amendment
with the Delaware Secretary of State’s office.
Item
9.01 Financial
Statements and Exhibits
| (d) |
Exhibits
|
|
3.1
|
Certificate
of Amendment to Amended and Restated Certificate of Incorporation
dated
July 16, 2007.
|
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| Dated: July 19, 2007 | NOVELOS THERAPEUTICS, INC. | |
| |
|
|
| By: | /s/ Harry S. Palmin | |
|
Name: Harry S. Palmin |
||
| Title: President and Chief Executive Officer | ||
3
EXHIBIT
INDEX
|
Exhibit
No.
|
Description
|
|
|
3.1
|
Certificate
of Amendment to Amended and Restated Certificate of Incorporation dated July 16,
2007
|
|
4